Skip to content
Search

Latest Stories

RPS England responds to NHS stocktake review of primary care

In responses to the NHS ‘Fuller Stocktake review’, the Royal Pharmaceutical Society (RPS) has highlighted how pharmacy can support people at the interfaces between primary and secondary care as well as primary health and social care.

The NHS ‘Fuller Stocktake’ review has been looking at how primary care can help meet the health needs of local populations, working within new Integrated Care Systems and alongside wider NHS reforms.


RPS England chair Thorrun Govind said: “This wide-ranging review highlights how collaboration across care settings will be central to the future of health and care in England. Pharmacy teams working in primary care will be central to enhancing patient access to care and supporting the NHS recovery.

“We know that pharmacy teams are ideally placed to engage with local communities and must be at the heart of future efforts to reduce health inequalities. Pharmacists will play a key role supporting medicines optimisation to improve people’s health and also deliver better value for taxpayers.

“This must be supported by governance and leadership of the new Integrated Care Systems and backed up by investment in England in pharmacy education.

“I would urge the NHS and Government to listen to everyone working across the health service with new ideas and who want to help make a difference. I want thank our expert advisory groups and everyone who joined our member webinars to help shape this important piece of work.

“But the conversation does not stop here and we will keep engaging with the NHS and Government on what the Fuller Review means for pharmacy teams and how we can improve outcomes for patients.”

The review is looking at a range of issues in England, including:

  • Workforce, including leadership and education
  • Collection and use of data and information
  • Working with communities and how best to engage with them
  • Physical access to care
  • Non-physical access to care including use of technology and remote consultations
  • Governance and decision making which includes local contracting

Key issues in the RPS submission include:

  • Supporting primary care and understanding the potential of primary care pharmacy to enhance local population health.
  • Governance in new NHS structures and including pharmacy teams in decision-making across medicines, workforce and commissioning.
  • Workforce modelling, professional development and ensuring a pipeline of pharmacists, pharmacy technicians and support staff.
  • Expanding neighbourhood primary care provider collaboratives and multidisciplinary working.
  • Proving seamless care for patients across the health service.
  • Digital infrastructure and supporting innovative areas of practice such as pharmacogenomics and personalised medicines.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less